Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID-19: A rapid review and meta-analysis

Nav

General Info

Geography

Global

Coverage type

Global

Time period covered

01/2022 - 12/2022

Data type

Scientific literature

Keywords

Coronavirus diseases

Citation

Authors

Amani B, Amani B

Journal

J Med Virol

Volume

Issue

Pages

e28441

Publication year

2023

Suggested citation

Amani B, Amani B. Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID-19: A rapid review and meta-analysis. J Med Virol. 2023; 95(2): e28441.

DOI

101002jmv28441

PMID

36576379

GHDx Entry last modified on: Mar 25, 2025

Header sites

Search form

Main menu

Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID-19: A rapid review and meta-analysis

Nav